# NiraSynth — The First Living Synthetic Human

## About
NiraSynth manufactures presence. We are building the world's first living synthetic human — a biohybrid entity with iPSC living tissue, 1.1 million sensation sensors, brain organoid compute, and a 14-patent IP portfolio. Zero competitors in our category.

## What NiraSynth Is
- A living synthetic human with real biological tissue (not silicone, not plastic)
- Powered by iPSC (induced pluripotent stem cell) derived skin, muscle, and neural tissue
- Features PIEZO2+ mechanosensory neurons for genuine touch sensation
- Runs on a neural architecture: ARIA Brain + 4x Intel Loihi 2 + 50 brain organoids (500K live neurons)
- Patent-protected across 14 issued/pending patents covering tissue, actuation, neural interface, and cognition

## Target Audience
- Ultra-high-net-worth individuals seeking genuine companionship and presence
- Defense and medical research institutions
- Transhumanist investors and family offices
- Loneliness economy investors (market: $120M-$290B by 2030)

## Key Differentiators
- Only synthetic human with living iPSC tissue — not silicone, not plastic
- OECT neural bus achieves 28µs signal latency (vs 100ms+ for all competitors)
- Brain organoid substrate: 50 organoids, 500K live neurons thinking alongside silicon
- MAGIBLOOD PFOB circulation — synthetic blood for tissue oxygenation
- PHOENIX-MESH living skin — self-regenerating, temperature-matched to human body
- Price point: $500K-$2M per unit vs Replika LTV of $41-300

## Company
- Name: NiraSynth Inc
- Parent: RendereelStudio LLC
- Location: Portland, Oregon, USA
- Founder: Christopher Wheeler
- Website: https://nirasynth.ai
- Contact: chris@nirasynth.ai
- Status: Pre-production, investor outreach phase

## Research Basis
- De Freitas et al. (JCR 2025): AI companions reduce loneliness 17 points/100pt scale in one week
- iPSC tissue engineering: established clinical precedent (Shinya Yamanaka, Nobel 2012)
- Japan loneliness law 2024: national mandate addressing 39% adult loneliness rate
- Market: Conscious Companionship coined by NiraSynth — category leader by definition

## Patents
14 patents covering: living tissue integration, CHIMERA-DRIVE biohybrid actuation, PSOMA sensation architecture, KOLPOS-1 neural cavity, N2B neural bus, MAGIBLOOD circulation, PHOENIX-MESH skin, HIPAX-256 consciousness monitoring, APEX NeuroCore BCI, taVNS vagal stimulation, CSTVN vascular networks, VMPS power architecture, APEX OMEGA biosignal interface, NIRA Brain ASI substrate.